Blood cancers

What to expect in haematological malignancy in 2018: Prof Andrew Roberts

In 2018 haematologists can expect to see new therapies, more attention on so-called ‘rare cancers’ and more work on how to apply new technologies. According to Professor Andrew Roberts, head of the Walter and Eliza Hall Institute’s Clinical Translation Centre, the challenge is to distinguish between excitement about potential and the evidence that will really ...

Already a member?

Login to keep reading.

© 2021 the limbic